apollo

Special offers

  1. Home
  2. Bevicra 400 mg Injection 16 ml

Bevicra 400 mg Injection 16 ml

Manufacturer/Marketer

Glenmark Pharmaceuticals Ltd

Consume Type

PARENTERAL

In Stock

Prescription Required
Product Details

About Bevicra 400 mg Injection 16 ml

Bevicra 400 mg Injection 16 ml is a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Cancer can start in one region of the body and spread to other parts. This is referred to as metastasis.

Bevicra 400 mg Injection 16 ml contains 'Bevacizumab' that works against vascular endothelial growth factor (VEGF) which is found on the lining of lymph and blood vessels. VEGF causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Inhibition of vascular endothelial growth factor limits the flow of oxygen and nutrients to the tumour, causing it to shrink or cease developing. Thus, it helps treat cancers.

Bevicra 400 mg Injection 16 ml will be administered by a healthcare professional; do not self-administer. Based on your medical condition, your doctor will decide the dose and duration. In some cases, Bevicra 400 mg Injection 16 ml may cause loss of appetite, constipation, fever, nosebleeds, change in speech, and taste. The majority of these side effects do not require medical treatment and fade away with time. However, consult your doctor if the side effects persist or worsen

Avoid taking Bevicra 400 mg Injection 16 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Bevicra 400 mg Injection 16 ml may cause sleepiness and fainting, so avoid driving while on treatment with Bevicra 400 mg Injection 16 ml. Do not breastfeed during the treatment and for 6months after the last dose of Bevicra 400 mg Injection 16 ml. Keep your doctor informed about your health condition and all the medicines you take to rule out any side effects.

Uses of Bevicra 400 mg Injection 16 ml

Metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum

Medicinal Benefits

Bevicra 400 mg Injection 16 ml contains Bevacizumab, a monoclonal antibody used to treat metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. Bevicra 400 mg Injection 16 ml works against a protein called vascular endothelial growth factor (VEGF). Vascular endothelial growth factor (VEGF) inhibition limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thus, it helps treat cancer.

Directions for Use

Bevicra 400 mg Injection 16 ml will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Bevicra 400 mg Injection 16 ml

  • Constipation
  • Loss of appetite
  • Fever
  • Nose bleeds
  • Change in speech
  • Change in taste
  • Voice changes/hoarseness
  • Loss of body weight

In-Depth Precautions and Warning

Drug Warnings

Bevicra 400 mg Injection 16 ml should only be taken under medical supervision. While taking Bevicra 400 mg Injection 16 ml, the doctor will monitor your condition on a regular basis. If you have a history of allergic reactions to Bevicra 400 mg Injection 16 ml or other medications, inform your doctor before taking it. Avoid taking Bevicra 400 mg Injection 16 ml if you are pregnant. Use effective contraception during the treatment and for 6months after the last dose. Bevicra 400 mg Injection 16 ml may cause sleepiness and fainting, so avoid driving while on treatment with Bevicra 400 mg Injection 16 ml. Inform your doctor if you have/had high blood pressure, heart attack, stroke, bleeding problems, stomach/intestinal bleeding, perforation; if you had surgery in the past 28days/are due to have surgery. Do not breastfeed during the treatment and for 6months after the last dose of Bevicra 400 mg Injection 16 ml. While taking Bevicra 400 mg Injection 16 ml, please do not get any immunizations or vaccinations unless your doctor has approved it. Bevicra 400 mg Injection 16 ml may increase the risk of bleeding, so be cautious and consult your doctor if you notice any bleeding or bruising.

Drug Interactions

Drug-Drug Interactions: Bevicra 400 mg Injection 16 ml may have interaction with a drug used to treat renal and gastrointestinal cancer (sunitinib) and platinum or taxane-based therapies for lung or metastatic breast cancer. Inform your doctor if you have recently received, or are receiving, radiotherapy.

Drug-Food Interactions: Avoid the consumption of alcohol while taking Bevicra 400 mg Injection 16 ml.

Drug-Disease Interactions: Inform your doctor if you have/had infections, bleeding disorders, fistula formation (an abnormal connection between two body parts), GI perforation, hypertension, PRES (Posterior Reversible Encephalopathy Syndrome), proteinuria (abnormal quantities of protein in the urine), and thromboembolic disorders.

Drug-Drug Interactions Checker List:

  • SUNITINIB
  • Safety Advice

    • Safety Warning

      Alcohol

      unsafe

      You are recommended to avoid alcohol consumption while taking Bevicra 400 mg Injection 16 ml. It could lead to unpleasant side effects.

    • Safety Warning

      Pregnancy

      unsafe

      Bevicra 400 mg Injection 16 ml should not be used during pregnancy because it causes harm to the fetus. Women of childbearing potential must use an effective contraception method while taking Bevicra 400 mg Injection 16 ml and at least six months after the last dose. Please consult your doctor about any concerns regarding this.

    • Safety Warning

      Breast Feeding

      unsafe

      Avoid breastfeeding during treatment and for 6months after the last dose. This is due to the possibility of the medication being passed on to the infant through breast milk.

    • Safety Warning

      Driving

      caution

      Caution should be exercised when driving or operating machinery because in some cases, Bevicra 400 mg Injection 16 ml may cause sleepiness and fainting.

    • Safety Warning

      Liver

      caution

      If you have/had a history of any liver-related diseases, please inform the doctor before taking Bevicra 400 mg Injection 16 ml. Your doctor will weigh the benefits and potential risks before prescribing Bevicra 400 mg Injection 16 ml.

    • Safety Warning

      Kidney

      caution

      If you have/had a history of any kidney-related diseases, please inform the doctor before taking Bevicra 400 mg Injection 16 ml. Your doctor will weigh the benefits and potential risks before prescribing Bevicra 400 mg Injection 16 ml.

    • Safety Warning

      Children

      unsafe

      Bevicra 400 mg Injection 16 ml is not recommended for children below 18years as the safety and effectiveness have not been established.

    Habit Forming

    No

    Diet & Lifestyle Advise

    • Meditating, reading novels, taking a nice bubble bath, or listening to calming music can all help you relax.
    • Yoga can also aid in the improvement of both physical and mental health.
    • Maintain a healthy weight by engaging in low-strain workouts on a regular basis and consuming nutritious foods.
    • To maintain a healthy weight, eat a portion of nutritious food and exercise on a regular basis.
    • Leafy greens, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs should all be part of your daily diet.
    • Rest well and get a good night's sleep.
    • Avoid smoking and consuming alcoholic beverages.
    • Fast food, fried foods, processed meats, refined carbohydrates, and added sugars should be avoided.

    Special Advise

    • Your doctor may perform routine blood tests to evaluate your liver function, electrolyte levels, and blood cell count.
    • Peripheral blood counts should be closely maintained during the treatment and, if necessary, until recovery.
    • Wear protective clothing, sunglasses, and sunscreen to avoid unnecessary or prolonged exposure to sunlight and UV rays (such as tanning booths). Your skin may become sun-sensitive as a result of Bevicra 400 mg Injection 16 ml.
    • Peripheral blood counts should be evaluated on a regular basis throughout Bevicra 400 mg Injection 16 ml treatment and until full recovery is achieved.

    Other Information (BEV0034)

    This item is Not Returnable.

    Expires on or after - Apr-24

    Patients Concern

    Disease/Condition Glossary

    Cancer: It is a condition where cells in a specific part of the body grow and reproduce uncontrollably. The cancerous cells can invade and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one part of the body and spreads to other areas. It occurs due to mutations in genes that regulate cell growth. The mutations cause the cells to divide and multiply in an uncontrolled manner, leading to tumour formation. The most common cancer treatment methods are surgery, chemotherapy, radiotherapy, bone marrow (stem cell) transplantation, immunotherapy, and targeted drug therapy.

    FAQs

    How does Bevicra 400 mg Injection 16 ml work?

    Bevicra 400 mg Injection 16 ml works against a protein called vascular endothelial growth factor (VEGF). Inhibition of vascular endothelial growth factor (VEGF) limits the flow of oxygen and nutrients to the tumour cells, causing them to shrink or cease developing. Thereby, Bevicra 400 mg Injection 16 ml helps treat cancer.

    Does Bevicra 400 mg Injection 16 ml cause Anaemia (low number of red blood cells)?

    Bevicra 400 mg Injection 16 ml may reduce the number of red blood cells leading to anaemia. Its symptoms include pale skin, lack of energy, feeling breathless, feeling dizzy and lightheadedness.

    Is chemotherapy still required for someone who is taking Bevicra 400 mg Injection 16 ml?

    Chemotherapy remains necessary. Bevicra 400 mg Injection 16 ml is given along with chemotherapy for treating cancer.

    I am due to undergo surgery, can I take Bevicra 400 mg Injection 16 ml?

    Bevicra 400 mg Injection 16 ml may increase the risk of bleeding and problems with wound healing. If you have had major surgery in the past 28days or if the wound hasn't healed, you should not take Bevicra 400 mg Injection 16 ml. Talk to your doctor for more information.

    Who is affected by cancer?

    Cancer can affect anyone, though the risk increases with age. Individual risk is determined by factors such as smoking and drinking habits, lifestyle choices such as what you eat and exercise; a family history of cancer, and factors in your workplace and environment.

    I have high blood pressure, Can I take Bevicra 400 mg Injection 16 ml?

    Bevicra 400 mg Injection 16 ml may increase the incidence of hypertension. Therefore, consult your doctor before taking Bevicra 400 mg Injection 16 ml if you have high blood pressure.

    PRODUCT SUBSTITUTES

    Bevicra 400 mg Injection 16 ml

    Disclaimer

    While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.

    Price :₹25500

    MRP ₹30000

    15%off

    (Inclusive of all taxes)

    Provide Delivery Location

    Vial

    16 ml Injection in 1 Vial